ARCHIVES

Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

Letrozole Combination Increases PFS In ER+ and HER2-Negative Breast Cancer

January 25, 2013

Obituary: Joan Mauer, 65, Chief, NCI Clinical Trials Monitoring Branch

October 15, 2010

NIAID Advisors Ok Recompetition of Pediatric ACTGs

February 14, 1992

In Brief: Tormey To Replace Carbone As ECOG chairman; Bishop Delivers First B.J. Kennedy Lecture

November 2, 1990

After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant

July 11, 2014

Two Studies Demonstrate Molecule Blocking Cell Damage

August 26, 2011